Neuphoria Therapeutics Inc (NEUP) earnings · rev $1.2M
These earnings events as JSON? API free 100/dayNeuphoria Therapeutics Inc (NEUP) is a biotechnology company listed on NASDAQ.
This NEUP earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported NEUP revenue for 2026-06-30 was $1.2M. Net income was -$13.5M. Revenue was down 92.5% from 2025-06-30 to 2026-06-30. NEUP currently screens at market cap $23.6M.
When the next NEUP 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 92.5% from 2025-06-30 to 2026-06-30. An earnings headline that ignores that move is noise.
Not investment advice. Full NEUP research stays on the stock page; the tape stays on the quote page.
NEUP earnings FAQ
What are NEUP's latest revenue and net income?
Latest cached Neuphoria Therapeutics Inc (NEUP) revenue for Jun 30, 2026 was $1.2M. Net income was -$13.5M. Statements: https://lician.com/financials/neup
What is NEUP's latest diluted EPS?
Latest cached Neuphoria Therapeutics Inc (NEUP) diluted EPS for Jun 30, 2026 was -$3.06.
What period does the latest NEUP earnings print cover?
The latest cached Neuphoria Therapeutics Inc (NEUP) earnings print covers Jun 30, 2026. The prior cached period on this page is Jun 30, 2025.
How did NEUP revenue change from the prior cached period?
Cached Neuphoria Therapeutics Inc (NEUP) revenue was down 92.5% from $15.6M (Jun 30, 2025) to $1.2M (Jun 30, 2026). Statements: https://lician.com/financials/neup
Where are NEUP earnings listed?
Cached earnings facts for Neuphoria Therapeutics Inc (NEUP) are listed at https://lician.com/earnings/neup. Statements: https://lician.com/financials/neup
Not investment advice.